Later stage investments in Chinese innovative companies continue. Alibaba and Yunfeng Capital have jointly invested $140 million in cloud service provider Qiniuyun while Shenzhen GTJA Investment has led a $45-million funding in Akeso Biopharma, a Guangdong-based antibody product manufacturer.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
